TY - JOUR
T1 - Correction to
T2 - Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead (Current Treatment Options in Oncology, (2023), 24, 5, (442-465), 10.1007/s11864-023-01072-5)
AU - Grinda, Thomas
AU - Rassy, Elie
AU - Pistilli, Barbara
N1 - Publisher Copyright:
© 2023 The Author(s).
PY - 2023/5/1
Y1 - 2023/5/1
N2 - The article "Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead", written by Thomas Grinda, Elie Rassy, and Barbara Pistilli, was originally published electronically on the publisher’s internet portal on March 25, 2023 without open access.
AB - The article "Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead", written by Thomas Grinda, Elie Rassy, and Barbara Pistilli, was originally published electronically on the publisher’s internet portal on March 25, 2023 without open access.
UR - http://www.scopus.com/inward/record.url?scp=85153097019&partnerID=8YFLogxK
U2 - 10.1007/s11864-023-01092-1
DO - 10.1007/s11864-023-01092-1
M3 - Comment/debate
C2 - 37069449
AN - SCOPUS:85153097019
SN - 1527-2729
VL - 24
SP - 466
EP - 467
JO - Current Treatment Options in Oncology
JF - Current Treatment Options in Oncology
IS - 5
ER -